MAGOG, Quebec — Industrial tire and track producer Camso Inc. teamed up with 24 of its dealer/distributors throughout the U.S. in August and September to raise funding for the Pancreatic Cancer Action Network.
The Camso Crushing Cancer 2019 initiative raised $144,957 for PanCAN, a Manhattan Beach, Calif.-based nonprofit dedicated to building awareness of the disease and securing support from Congress to increase the research investment in the disease.
Camso donated, on behalf of its participating dealers, a portion of the proceeds from the sale of select construction tires, the Magog-based company said.
"When we launched this program last August, little did we know that we would be able to raise such an important amount for our donation to the Pancreatic Cancer Action Network," Jim Donoghue, director, marketing and sales support – North America, said.
"Most of us know families who have been affected by this disease, and we are proud to support this cause."
Dealerships that participated in the initiative were:
Best One Tire of Indianapolis; Blue Ribbon Tire of Phoenix; Cassidy Tire of Chicago; Commercial Tire of Boise, Idaho; Dakota Tire of Fargo, N.D.; Gallagher Tire of Levittown, Pa.; Lapps Loader Service L.L.C. of Narvon, Pa.; McCarthy Tire of Wilkes-Barre, Pa.; Midstate Tire Distributors of Columbia, S.C.; Northwest Tire Factory/Point S Tire of Portland, Ore.; Parkhouse Tire Inc. of Bell Gardens, Calif.; Pomp's Tire Service Inc. of Green Bay, Wis.; Quality Tire Co. of Salt Lake City; Ray's Tire Service of San Antonio; Redburn Tire Co. of Phoenix; Royal Tire of St. Cloud, Minn.; Service Tire & Truck Center of Bethlehem, Pa.; Southern Tire Mart of Columbia, Miss.; Sullivan Tire of Woburn, Mass.; Tandem Tire & Auto Service of Dubuque, Iowa; TF Tire & Service of Tulare, Calif.; Tiresoles Group of Pompano Beach, Fla.; United Tire Centers of Temecula, Calif.; and Goodyear's Wingfoot Commercial Tire Centers network.
Brooke Caviglia, PanCAN associate director, community engagement, said: "We are sincerely grateful for this generous gift from Camso and their dealers. Their support will directly benefit thousands of pancreatic cancer patients and their families and will help in our fight against this deadly disease."
According to PanCAN, pancreatic cancer is the third leading cause of cancer-related death in the U.S., with a five-year survival rate of just 9%.
Funds raised for PanCAN through the Camso Crushing Cancer program will advance critical research programs, including PanCAN's Clinical Trial initiative, Precision PromiseSM, Early Detection Initiative (EDI), precision medicine initiative Know Your Tumo, additional field research, and other patient advocacy efforts, Camso said.